BR112017017599A2 - métodos para modular respostas imunológicas e inflamatórias pela administração de uma biomassa algal - Google Patents

métodos para modular respostas imunológicas e inflamatórias pela administração de uma biomassa algal

Info

Publication number
BR112017017599A2
BR112017017599A2 BR112017017599A BR112017017599A BR112017017599A2 BR 112017017599 A2 BR112017017599 A2 BR 112017017599A2 BR 112017017599 A BR112017017599 A BR 112017017599A BR 112017017599 A BR112017017599 A BR 112017017599A BR 112017017599 A2 BR112017017599 A2 BR 112017017599A2
Authority
BR
Brazil
Prior art keywords
algal
methods
algal biomass
biomass
administering
Prior art date
Application number
BR112017017599A
Other languages
English (en)
Other versions
BR112017017599B1 (pt
Inventor
E Steffek Amy
A Dahl Andrew
Original Assignee
Zivo Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zivo Bioscience Inc filed Critical Zivo Bioscience Inc
Publication of BR112017017599A2 publication Critical patent/BR112017017599A2/pt
Publication of BR112017017599B1 publication Critical patent/BR112017017599B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/02—Antioxidant
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

uma biomassa algal e sobrenadante derivados de ao menos uma espécie de algas exibem propriedades moduladoras das respostas anti-inflamatória e imuno-lógica. métodos para reduzir os sintomas de ou tratar uma condição ou doença em um animal, incluindo a mastite bovina e o complexo das doenças respiratórias bovinas, bem como a dor e desconforto causados por osteoartrite, lesão ou estira-mento ou distensões em tecidos musculares e conectivos, compreendem adminis-trar ao animal que deles necessita uma biomassa algal ou sobrenadante derivados de ao menos uma espécie de algas, ou um extrato, derivado ou composto biologi-camente ativo derivados da espécie de algas, biomassa ou sobrenadante, ou com-posições dos mesmos.
BR112017017599-1A 2015-02-16 2016-02-16 Usos de uma biomassa algal ou de um sobrenadante derivado de ao menos uma espécie de algas klebsormidium BR112017017599B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562116766P 2015-02-16 2015-02-16
US62/116,766 2015-02-16
PCT/US2016/018105 WO2016133922A1 (en) 2015-02-16 2016-02-16 Methods of modulating immune and inflammatory responses via administration of an algal biomass

Publications (2)

Publication Number Publication Date
BR112017017599A2 true BR112017017599A2 (pt) 2018-05-08
BR112017017599B1 BR112017017599B1 (pt) 2021-11-16

Family

ID=56689161

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017017599-1A BR112017017599B1 (pt) 2015-02-16 2016-02-16 Usos de uma biomassa algal ou de um sobrenadante derivado de ao menos uma espécie de algas klebsormidium

Country Status (7)

Country Link
US (1) US11065287B2 (pt)
EP (1) EP3258948B1 (pt)
BR (1) BR112017017599B1 (pt)
CA (1) CA3011687A1 (pt)
HK (1) HK1248545A1 (pt)
PL (1) PL3258948T3 (pt)
WO (1) WO2016133922A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
EP2538951B1 (en) 2010-02-22 2020-04-22 Health Enhancement Products Inc. Agents and mechanisms for preventing hypercholesterolemia
WO2014201372A1 (en) 2013-06-13 2014-12-18 Health Enhancement Products, Inc. Compounds and methods for affecting cytokines
EP3258948B1 (en) 2015-02-16 2023-12-06 Zivo Bioscience, Inc. Anti-inflammatory and immunomodulatory compositions comprising klebsormidium and uses thereof
EP3416501A4 (en) 2016-02-16 2019-11-20 Zivo Bioscience, Inc. NUTRITIONAL SUPPORT OF ANIMALS BY ADMINISTRATION OF A SUPPLEMENT BASED ON ALGAE
PE20191537A1 (es) * 2017-03-07 2019-10-23 Zivo Bioscience Inc Suplementos alimenticios, ingredientes alimentarios y alimentos que comprenden biomasa de algas con alto contenido de proteinas
JP2023553202A (ja) 2020-12-08 2023-12-20 ルミナント バイオテク コーポレーション リミテッド 動物に物質を送達するための装置および方法の改善
CN117157066A (zh) * 2021-01-15 2023-12-01 齐沃生物科学股份有限公司 用于预防和治疗疾病的嗜冷菌属、包西氏菌属、短波单胞菌属、脱硫弧菌属、微杆菌属、鞘氨醇单胞菌属和贪噬菌属

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012504A (en) * 1972-05-12 1977-03-15 Velvet Chemical Co. Iodine mineral oil solution for preventing bovine mastitis
JPS55142249A (en) 1979-04-24 1980-11-06 Shionogi & Co Ltd Reduction type ascorbic acid detecting composition and test piece
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4471055A (en) 1982-03-26 1984-09-11 Minnesota Mining And Manufacturing Company Process and kit for determining concentrations of aldehydes
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
JPS6219528A (ja) 1985-07-16 1987-01-28 Kurorera Kogyo Kk 制癌剤
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4925678A (en) 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5167616A (en) 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
US6631842B1 (en) 2000-06-07 2003-10-14 Metrologic Instruments, Inc. Method of and system for producing images of objects using planar laser illumination beams and image detection arrays
US5225182A (en) 1991-10-31 1993-07-06 Sharma Yash P Vectored drug delivery system using a cephaloplastin linking agent and a methed of using the system
WO1994024984A2 (en) 1993-04-30 1994-11-10 Winget Rodner R Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
US5726063A (en) 1993-05-06 1998-03-10 Oxis Isle Of Man, Limited Method of colorimetric analysis of malonic dialdehyde and 4-hydroxy-2-enaldehydes as indexes of lipid peroxidation, kits for carrying out said method, substituted indoles for use in said method and their preparation
JPH0940523A (ja) 1995-07-28 1997-02-10 Ichimaru Pharcos Co Ltd クロレラ水抽出物含有線維芽細胞増殖促進物質
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US6673908B1 (en) 1999-02-22 2004-01-06 Nuvelo, Inc. Tumor necrosis factor receptor 2
ATE270558T1 (de) 1999-08-26 2004-07-15 Ganeden Biotech Inc Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
AU7551100A (en) 1999-09-27 2001-04-30 Algal Ltd. Vegetarian foodstuff
US6235495B1 (en) 1999-11-12 2001-05-22 Oxis International, Inc. Methods for the quantitation of oxidized glutathione
CA2354832C (en) 2000-08-10 2002-05-14 Ocean Nutrition Canada Ltd. Chlorella preparations exhibiting immunomodulating properties
US20020119164A1 (en) 2000-08-18 2002-08-29 Shoji Uchiyama Use of agaricus blazei murill to prevent or treat skin and other disorders
EP1230927A1 (en) 2001-02-12 2002-08-14 Allegrini S.p.a. Phyto-derivative disinfectant solution for veterinary use in the endo-mammary anti-mastitis treatment of milk-producing animals
US7578132B2 (en) 2001-03-03 2009-08-25 Rolls-Royce Plc Gas turbine engine exhaust nozzle
US6374874B1 (en) 2001-06-22 2002-04-23 Robert W. Payne Sand bag loading system
TWI318881B (pt) 2001-09-27 2010-01-01
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
AU2003287622A1 (en) 2002-11-06 2004-06-03 Fraunhofer Usa Expression of foreign sequences in plants using trans-activation system
US7025965B1 (en) 2003-02-12 2006-04-11 Pharma Chemie, Inc. Method of use and dosage composition of bluegreen algae extract for inflammation in animals
DE10324548A1 (de) 2003-05-28 2004-12-16 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätisches Lebensmittel bei einer gewichtskontrollierenden bzw. gewichtsreduzierenden Ernährung
US20050260695A1 (en) 2003-09-23 2005-11-24 Genprime, Inc. Methods, compositions, devices, and kits for detecting mastitis
US20110117122A1 (en) 2009-11-16 2011-05-19 Tiffany Thomas COMPOSITION AND METHOD FOR AFFECTING CYTOKINES AND NF-kB
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US20080031863A1 (en) 2004-04-23 2008-02-07 Health Enhancement Products, Inc. Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease
US20130251698A1 (en) 2010-10-04 2013-09-26 Health Enhancement Products, Inc. Composition and method for affecting cytokines and nf-kb
US7807622B2 (en) 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
CA2485449A1 (en) * 2004-10-08 2006-04-08 Biotec Pharmacon Asa Method for preventing mucositis during cancer therapy
US7854467B2 (en) 2004-11-05 2010-12-21 General Motors Corporation Airflow control devices based on active materials
US7216831B2 (en) 2004-11-12 2007-05-15 The Boeing Company Shape changing structure
US7546727B2 (en) 2004-11-12 2009-06-16 The Boeing Company Reduced noise jet engine
WO2007065024A2 (en) 2005-12-02 2007-06-07 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
EP1928247A4 (en) 2005-04-20 2009-10-28 Health Enhancement Products In COMPOSITION AND USE OF PHYTO-PERCOLATE FOR THE TREATMENT OF DISEASE
US8586053B2 (en) 2005-09-21 2013-11-19 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US20080089843A1 (en) 2006-05-25 2008-04-17 Reddy's Laboratories, Inc. Use of biomarkers of inflammation as indicators of drug efficacy
EP2037740A4 (en) 2006-06-07 2011-12-28 Reddys Lab Ltd Dr COMPOSITIONS AND METHODS FOR IMPROVING THE REVERSE CHOLESTER INTRANSPORT
WO2008014058A2 (en) 2006-06-20 2008-01-31 Usa As Represented By The Administrator Of The National Aeronautics & Space Administration Jet engine exhaust nozzle flow effector
GB0614114D0 (en) 2006-07-15 2006-08-23 Rolls Royce Plc An actuator
WO2008039911A1 (en) 2006-09-28 2008-04-03 Purrfect Gourmet, Llc Algal biomeal-based palatability enhancer and method of use and manufacture therefor
WO2010017346A2 (en) 2008-08-08 2010-02-11 The Dial Corporation Consumer products comprising algae derived ingredients
US8434293B2 (en) 2009-08-06 2013-05-07 The Boeing Company High stiffness shape memory alloy actuated aerostructure
WO2011072283A2 (en) 2009-12-11 2011-06-16 Rettenmaier Albert C Methods of algae harvesting utilizing a filtering substance and uses therefor
EP2538951B1 (en) 2010-02-22 2020-04-22 Health Enhancement Products Inc. Agents and mechanisms for preventing hypercholesterolemia
US8685707B2 (en) 2010-06-14 2014-04-01 Heinz Ploechinger Construction material made of algae, method for cultivating algae, and algae cultivation plant
CN102225127B (zh) * 2011-06-21 2012-08-15 北京九草堂药物研究院有限公司 一种治疗奶牛乳腺炎的中药组合物
JP2014006051A (ja) * 2012-06-21 2014-01-16 Univ Of Tsukuba 放射性同位元素の除去剤および除去方法
WO2014201372A1 (en) * 2013-06-13 2014-12-18 Health Enhancement Products, Inc. Compounds and methods for affecting cytokines
EP3258948B1 (en) 2015-02-16 2023-12-06 Zivo Bioscience, Inc. Anti-inflammatory and immunomodulatory compositions comprising klebsormidium and uses thereof
EP3416501A4 (en) 2016-02-16 2019-11-20 Zivo Bioscience, Inc. NUTRITIONAL SUPPORT OF ANIMALS BY ADMINISTRATION OF A SUPPLEMENT BASED ON ALGAE
PE20191537A1 (es) 2017-03-07 2019-10-23 Zivo Bioscience Inc Suplementos alimenticios, ingredientes alimentarios y alimentos que comprenden biomasa de algas con alto contenido de proteinas

Also Published As

Publication number Publication date
EP3258948A1 (en) 2017-12-27
WO2016133922A1 (en) 2016-08-25
US11065287B2 (en) 2021-07-20
EP3258948C0 (en) 2023-12-06
PL3258948T3 (pl) 2024-04-22
HK1248545A1 (zh) 2018-10-19
EP3258948B1 (en) 2023-12-06
US20180021392A1 (en) 2018-01-25
CA3011687A1 (en) 2016-08-25
EP3258948A4 (en) 2018-09-12
BR112017017599B1 (pt) 2021-11-16

Similar Documents

Publication Publication Date Title
BR112017017599A2 (pt) métodos para modular respostas imunológicas e inflamatórias pela administração de uma biomassa algal
BR112017011923A2 (pt) bactéria modificada para tratar doenças associadas com hiperamonemia
EA201800367A1 (ru) Способы лечения болезни хантингтона
EA201800199A1 (ru) Применение akkermansia muciniphila для лечения метаболических расстройств, увеличения расхода энергии и снижения веса, композиции, лекарственное стедство
BR112016010166A2 (pt) métodos para usar interleucina-10 para tratar doenças e distúrbios
EA201890725A1 (ru) Агонисты фарнезоидного х-рецептора и их применение
BR112018074927A2 (pt) uso de indazóis substituídos para tratamento e prevenção de doenças alérgicas e/ou inflamatórias em animais
BR112014008044A8 (pt) bactéria para uso como um probiótico para aplicações nutricionais e médicas
BR112018070962A2 (pt) espécies bacterianas inovadoras
CO7151524A2 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciación y usos de los mismos
BR112014026744A8 (pt) anticorpo isolado ou fragmento de anticorpo, composição de anticorpo ou composição de fragmento de anticorpo, uso de modulação imune, uso de pelo menos uma composição de anticorpo ou fragmento de anticorpo, dispositivo médico, formulação, kit, artigo de fabricação para uso farmacêutico humano, método para produzir um anticorpo ou fragmento, animal ou planta transgênica, e, anticorpo ou porção ou variante especificada.
BR112015026122A2 (pt) métodos para usar interleucina-10 para tratar doenças e desordens
BR112017014332A2 (pt) métodos de tratamento de doenças retinianas
EA201700336A1 (ru) Композиция, включающая хитин и переваримые белки
BR112017011838A2 (pt) polímeros de ligação a prótons para administração oral
BR112013026447A2 (pt) métodos para a regulação da expressão de gene de sirtuína
CL2021000033A1 (es) Nuevos compuestos
WO2016029136A8 (en) 3-amidobenzamides and uses thereof for increasing cellular levels of a3g
BR112015006656A8 (pt) composições e métodos para o tratamento de insuficiência cardíaca em pacientes diabéticos
EA201490637A1 (ru) Растительные стероиды и их применения
EA201891007A1 (ru) Нацеливание на формилпептидный рецептор 2/рецептор липоксина a(fpr2/alx) для лечения заболеваний сердца
BR112015022044A2 (pt) um método de proporcionar neutroproteção ocular
FR2954945B1 (fr) Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
BR112021018918A2 (pt) Compostos e composições como moduladores de sinalização de tlr
EA202091112A1 (ru) Сокристаллы, фармацевтические композиции на их основе и способы лечения, предусматривающие их применение

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/02/2016, OBSERVADAS AS CONDICOES LEGAIS.